Decoy Therapeutics Inc. (DCOY) has 10 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 2, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 2, 2026 filed Aug. 31, 2026 | Lieber Jonathan I Director | $0 | 2,000 | +100000% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | PIERCE FREDERICK II Chief Executive Officer | $0 | 33,455 | +2409% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | Marschel Peter Klaus Chief Business Officer | $0 | 3,900 | New | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | Rosenblum Mark J Chief Financial Officer | $0 | 9,682 | +576% | No | |
|
|
||||||
| Sept. 2, 2026 filed Aug. 31, 2026 | Hibner Barbara Louise Chief Scientific Officer | $0 | 4,216 | New | No | |
|
|
||||||
Showing the 5 most recent of 10 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free